标题
Principles of the activin receptor signaling pathway and its inhibition
作者
关键词
Growth factor, IASP, Muscle, Bone, Hematopoiesis
出版物
CYTOKINE & GROWTH FACTOR REVIEWS
Volume 60, Issue -, Pages 1-17
出版商
Elsevier BV
发表日期
2021-04-21
DOI
10.1016/j.cytogfr.2021.04.001
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity
- (2021) Steven B. Heymsfield et al. JAMA Network Open
- Structural basis for specific inhibition of extracellular activation of pro- or latent myostatin by the monoclonal antibody SRK-015
- (2020) Kevin B Dagbay et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes
- (2020) Pierre Fenaux et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
- (2020) M. Domenica Cappellini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults
- (2020) Daniel Rooks et al. JAMA Network Open
- Compression of morbidity in a progeroid mouse model through the attenuation of myostatin/activin signalling
- (2019) Khalid Alyodawi et al. Journal of Cachexia Sarcopenia and Muscle
- A follistatin-based molecule increases muscle and bone mass without affecting the red blood cell count in mice
- (2019) Andreas Lodberg et al. FASEB JOURNAL
- Lack of Gdf11 does not improve anemia or prevent the activity of RAP-536 in a mouse model of beta-thalassemia
- (2019) Amaliris Guerra et al. BLOOD
- Steady-state and regenerative hematopoiesis occur normally in mice in the absence of GDF11
- (2019) Jill M. Goldstein et al. BLOOD
- Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial
- (2019) Michael G Hanna et al. LANCET NEUROLOGY
- Sarcopenia as a mortality predictor in community-dwelling older adults: a comparison of the diagnostic criteria of the European Working Group on Sarcopenia in Older People
- (2019) Nathalia Perleberg Bachettini et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- P.126SRK-015, a fully human monoclonal antibody inhibiting myostatin activation, offers sustained target engagement across multiple species, including humans
- (2019) A. Kalra et al. NEUROMUSCULAR DISORDERS
- Follistatin-based ligand trap ACE-083 induces localized hypertrophy of skeletal muscle with functional improvement in models of neuromuscular disease
- (2019) R. S. Pearsall et al. Scientific Reports
- Sarcopenia in COPD: a systematic review and meta-analysis
- (2019) Elizabeth Benz et al. European Respiratory Review
- What can we learn from ineffective erythropoiesis in thalassemia?
- (2018) Paraskevi Rea Oikonomidou et al. BLOOD REVIEWS
- A soluble activin type IIA receptor mitigates the loss of femoral neck bone strength and cancellous bone mass in a mouse model of disuse osteopenia
- (2018) Andreas Lodberg et al. BONE
- Effects of bimagrumab, an activin receptor type II inhibitor, on pituitary neurohormonal axes
- (2018) Tania Garito et al. CLINICAL ENDOCRINOLOGY
- Tolloid cleavage activates latent GDF8 by priming the pro‐complex for dissociation
- (2018) Viet Q Le et al. EMBO JOURNAL
- Myogenic regulatory factors: The orchestrators of myogenesis after 30 years of discovery
- (2018) Hasan A Asfour et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Locally acting ACE-083 increases muscle volume in healthy volunteers
- (2018) Chad E. Glasser et al. MUSCLE & NERVE
- Inhibin βE (INHBE) is a possible insulin resistance-associated hepatokine identified by comprehensive gene expression analysis in human liver biopsy samples
- (2018) Masakazu Sugiyama et al. PLoS One
- Molecular characterization of latent GDF8 reveals mechanisms of activation
- (2018) Ryan G. Walker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sarcopenia: a chronic complication of type 2 diabetes mellitus
- (2018) Heloísa Trierweiler et al. Diabetology & Metabolic Syndrome
- Blocking extracellular activation of myostatin as a strategy for treating muscle wasting
- (2018) M. Pirruccello-Straub et al. Scientific Reports
- Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trial
- (2018) Rami Komrokji et al. Lancet Haematology
- OUP accepted manuscript
- (2018) AGE AND AGEING
- Normal and pathologic erythropoiesis in adults: from gene regulation to targeted treatment concepts
- (2018) Peter Valent et al. HAEMATOLOGICA
- CMT AND NEUROGENIC DISEASE
- (2018) M. Shy et al. NEUROMUSCULAR DISORDERS
- FSHD / OPMD / EDMD / DMI
- (2018) J. Statland et al. NEUROMUSCULAR DISORDERS
- LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial
- (2018) Talia Golan et al. Journal of Cachexia Sarcopenia and Muscle
- Follistatin-288-Fc Fusion Protein Promotes Localized Growth of Skeletal Muscle
- (2018) Roselyne Castonguay et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Biochemical and Cellular Analysis Reveals Ligand Binding Specificities, a Molecular Basis for Ligand Recognition, and Membrane Association-dependent Activities of Cripto-1 and Cryptic
- (2017) Senem Aykul et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof-of-Concept Study
- (2017) Daniel Rooks et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study
- (2017) Uwe Platzbecker et al. LANCET ONCOLOGY
- Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption
- (2017) N. Doyle et al. OSTEOPOROSIS INTERNATIONAL
- Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy
- (2017) Frederic Morvan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activin A more prominently regulates muscle mass in primates than does GDF8
- (2017) Esther Latres et al. Nature Communications
- A muscle-specific MuRF1-E2 network requires stabilization of MuRF1-E2 complexes by telethonin, a newly identified substrate
- (2017) Cécile Polge et al. Journal of Cachexia Sarcopenia and Muscle
- Effect of bimagrumab on thigh muscle volume and composition in men with casting-induced atrophy
- (2017) Daniel S. Rooks et al. Journal of Cachexia Sarcopenia and Muscle
- A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys
- (2017) Michael St. Andre et al. Skeletal Muscle
- Sarcopenia in patients with chronic kidney disease not yet on dialysis: Analysis of the prevalence and associated factors
- (2017) Viviane Angelina de Souza et al. PLoS One
- Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease
- (2016) Marissa J. Schafer et al. Cell Metabolism
- Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial
- (2016) Craig Campbell et al. MUSCLE & NERVE
- GDF11 decreases bone mass by stimulating osteoclastogenesis and inhibiting osteoblast differentiation
- (2016) Weiqing Liu et al. Nature Communications
- TGF- signaling in the control of hematopoietic stem cells
- (2015) U. Blank et al. BLOOD
- GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration
- (2015) Marc A. Egerman et al. Cell Metabolism
- Rapid Activation of Bone Morphogenic Protein 9 by Receptor-mediated Displacement of Pro-domains
- (2015) Yvonne Kienast et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Myostatin Neutralization Results in Preservation of Muscle Mass and Strength in Preclinical Models of Tumor-Induced Muscle Wasting
- (2015) R. C. Smith et al. MOLECULAR CANCER THERAPEUTICS
- Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice
- (2015) Berno Dankbar et al. NATURE MEDICINE
- Structure of bone morphogenetic protein 9 procomplex
- (2015) Li-Zhi Mi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies
- (2015) Haralambos Raftopoulos et al. SUPPORTIVE CARE IN CANCER
- Evaluation of follistatin as a therapeutic in models of skeletal muscle atrophy associated with denervation and tenotomy
- (2015) Patricio V. Sepulveda et al. Scientific Reports
- Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial
- (2015) Clemens Becker et al. Lancet Diabetes & Endocrinology
- Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice
- (2015) Esther Latres et al. Skeletal Muscle
- Emerging roles of BMP9 and BMP10 in hereditary hemorrhagic telangiectasia
- (2015) Emmanuelle Tillet et al. Frontiers in Genetics
- RAP-011, an activin receptor ligand trap, increases hemoglobin concentration in hepcidin transgenic mice
- (2014) Jacqueline M. Langdon et al. AMERICAN JOURNAL OF HEMATOLOGY
- A phase 1 study of ACE-536, a regulator of erythroid differentiation, in healthy volunteers
- (2014) Kenneth M. Attie et al. AMERICAN JOURNAL OF HEMATOLOGY
- An activin receptor IIA ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin
- (2014) Soraya Carrancio et al. BRITISH JOURNAL OF HAEMATOLOGY
- Sotatercept in patients with osteolytic lesions of multiple myeloma
- (2014) Kudrat M. Abdulkadyrov et al. BRITISH JOURNAL OF HAEMATOLOGY
- Pharmacological Inhibition of Myostatin and Changes in Lean Body Mass and Lower Extremity Muscle Size in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
- (2014) Desmond Padhi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia
- (2014) Michael Dussiot et al. NATURE MEDICINE
- Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis
- (2014) Rajasekhar N V S Suragani et al. NATURE MEDICINE
- Treatment of sporadic inclusion body myositis with bimagrumab
- (2014) A. A. Amato et al. NEUROLOGY
- Vascular and Neurogenic Rejuvenation of the Aging Mouse Brain by Young Systemic Factors
- (2014) L. Katsimpardi et al. SCIENCE
- miR-21 mediates hematopoietic suppression in MDS by activating TGF- signaling
- (2013) T. D. Bhagat et al. BLOOD
- Multiple-dose, safety, pharmacokinetic, and pharmacodynamic study of sotatercept (ActRIIA-IgG1), a novel erythropoietic agent, in healthy postmenopausal women
- (2013) Matthew L. Sherman et al. JOURNAL OF CLINICAL PHARMACOLOGY
- An Antibody Blocking Activin Type II Receptors Induces Strong Skeletal Muscle Hypertrophy and Protects from Atrophy
- (2013) E. Lach-Trifilieff et al. MOLECULAR AND CELLULAR BIOLOGY
- A Novel Therapeutic Approach to Treating Obesity through Modulation of TGFβ Signaling
- (2012) Alan Koncarevic et al. ENDOCRINOLOGY
- Stromal cell-mediated inhibition of erythropoiesis can be attenuated by Sotatercept (ACE-011), an activin receptor type II ligand trap
- (2012) Camelia Iancu-Rubin et al. EXPERIMENTAL HEMATOLOGY
- Specificity and Structure of a High Affinity Activin Receptor-like Kinase 1 (ALK1) Signaling Complex
- (2012) Sharon A. Townson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of satellite cells versus myofibers in muscle hypertrophy induced by inhibition of the myostatin/activin signaling pathway
- (2012) S.-J. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting the Activin Type IIB Receptor to Improve Muscle Mass and Function in the mdx Mouse Model of Duchenne Muscular Dystrophy
- (2011) Emidio E. Pistilli et al. AMERICAN JOURNAL OF PATHOLOGY
- Myostatin promotes the wasting of human myoblast cultures through promoting ubiquitin-proteasome pathway-mediated loss of sarcomeric proteins
- (2011) Sudarsanareddy Lokireddy et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Reducing Noninfectious Risks of Blood Transfusion
- (2011) Brian M. Gilliss et al. ANESTHESIOLOGY
- Myostatin induces autophagy in skeletal muscle in vitro
- (2011) Jen Y. Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Generation of a Specific Activin Antagonist by Modification of the Activin A Propeptide
- (2011) Yogeshwar Makanji et al. ENDOCRINOLOGY
- Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease
- (2011) Liping Zhang et al. FASEB JOURNAL
- Bone mineralization
- (2011) Ermanno Bonucci Frontiers in Bioscience-Landmark
- Building strong bones: molecular regulation of the osteoblast lineage
- (2011) Fanxin Long NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy
- (2011) Victoria C. Foletta et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Induction of Heart Valve Lesions by Small-Molecule ALK5 Inhibitors
- (2011) Mark J. Anderton et al. TOXICOLOGIC PATHOLOGY
- Identification and analysis of type II TGF- receptors in BMP-9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells
- (2010) N. Wu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeys
- (2010) Sutada Lotinun et al. BONE
- Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
- (2010) Xiaolan Zhou et al. CELL
- A Soluble Activin Receptor Type IIB Prevents the Effects of Androgen Deprivation on Body Composition and Bone Health
- (2010) Alan Koncarevic et al. ENDOCRINOLOGY
- Characterization of the Ligand Binding Functionality of the Extracellular Domain of Activin Receptor Type IIB
- (2010) Dianne Sako et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size
- (2009) Anne Ulrike Trendelenburg et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Smad2 and 3 transcription factors control muscle mass in adulthood
- (2009) Roberta Sartori et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Stimulation of skeletal muscle myofibrillar protein synthesis, p70 S6 kinase phosphorylation, and ribosomal protein S6 phosphorylation by inhibition of myostatin in mature mice
- (2009) Stephen Welle et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding
- (2009) Jennifer N Cash et al. EMBO JOURNAL
- Hematocrit and risk of venous thromboembolism in a general population. The Tromso study
- (2009) S. K. Braekkan et al. HAEMATOLOGICA
- Bisphosphonates: Mechanism of Action and Role in Clinical Practice
- (2009) Matthew T. Drake et al. MAYO CLINIC PROCEEDINGS
- Measurement of myostatin concentrations in human serum: Circulating concentrations in young and older men and effects of testosterone administration
- (2009) Kishore M. Lakshman et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Activin C Antagonizes Activin A in Vitro and Overexpression Leads to Pathologies in Vivo
- (2008) Elspeth Gold et al. AMERICAN JOURNAL OF PATHOLOGY
- A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy
- (2008) Kathryn R. Wagner et al. ANNALS OF NEUROLOGY
- Osteoclast lineage and function
- (2008) H. Kalervo Väänänen et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Inhibition of the TGF- receptor I kinase promotes hematopoiesis in MDS
- (2008) L. Zhou et al. BLOOD
- Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study of ACE-011 (ActRIIA-IgG1) in Postmenopausal Women*
- (2008) Jon Ruckle et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Proteomic Identification and Functional Validation of Activins and Bone Morphogenetic Protein 11 as Candidate Novel Muscle Mass Regulators
- (2008) Tatyana A. Souza et al. MOLECULAR ENDOCRINOLOGY
- Single muscle fiber contractile properties in adults with muscular dystrophy treated with MYO-029
- (2008) Lisa S. Krivickas et al. MUSCLE & NERVE
- A soluble activin Type IIA receptor induces bone formation and improves skeletal integrity
- (2008) R. S. Pearsall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anabolic steroids in COPD: a review and preliminary results of a randomized trial
- (2008) S Sharma et al. Chronic Respiratory Disease
- Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure
- (2007) Karien van der Putten et al. Nature clinical practice. Nephrology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started